Medizen Humancare Inc Co., Ltd Logo

Medizen Humancare Inc Co., Ltd

Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.

236340 | KO

Overview

Corporate Details

ISIN(s):
KR7236340006
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로7길 6 PNS홈즈타워 6층, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medizen Humancare Inc Co., Ltd. is a biotechnology research company specializing in genomics-based personalized healthcare. Established in 2012, the company's core business is genomic analysis to predict individual disease risks. It provides direct-to-consumer (DTC) genetic testing and disease risk analysis services using genetic chips and analysis kits. By leveraging genomic big data, Medizen Humancare aims to advance precision medicine and deliver customized healthcare solutions based on an individual's genetic information.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-13 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-04-28 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 16.2 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.4 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 143.7 KB
2025-02-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.8 KB
2024-12-31 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 31.5 KB
2024-12-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 71.6 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-04 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2024-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 79.2 KB
2024-06-26 00:00
Related Party Transaction
타법인주식및출자증권취득결정
Korean 13.7 KB
2024-06-26 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 35.4 KB

Automate Your Workflow. Get a real-time feed of all Medizen Humancare Inc Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medizen Humancare Inc Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medizen Humancare Inc Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.